Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioMagnetic Sciences is a private medical device company focused on non-invasive pain management and musculoskeletal care. The company is best known for NovoPulse, a pulsed electromagnetic field and thermal stimulation system marketed for osteoarthritis and spine-related pain management. Available sources describe the business as a for-profit, Minnesota-based healthcare company founded in 2011, with commercialization directed primarily toward clinical and chiropractic use. Rather than developing drugs or biologics, BioMagnetic Sciences appears to operate in the medical technology segment, offering device-based therapy intended to reduce pain and improve function. Publicly available evidence indicates a narrow commercial portfolio centered on NovoPulse rather than a broad therapeutic pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioMagnetic Sciences.